871 related articles for article (PubMed ID: 9723965)
1. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
2. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
3. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Eur J Pharmacol; 2009 May; 609(1-3):78-87. PubMed ID: 19285064
[TBL] [Abstract][Full Text] [Related]
4. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
Wieland HA; Engel W; Eberlein W; Rudolf K; Doods HN
Br J Pharmacol; 1998 Oct; 125(3):549-55. PubMed ID: 9806339
[TBL] [Abstract][Full Text] [Related]
5. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
[TBL] [Abstract][Full Text] [Related]
6. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuropeptide Y on food intake and brain biogenic amines in the rainbow trout (Oncorhynchus mykiss).
Aldegunde M; Mancebo M
Peptides; 2006 Apr; 27(4):719-27. PubMed ID: 16253390
[TBL] [Abstract][Full Text] [Related]
10. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist.
Fang Q; Guo J; He F; Peng YL; Chang M; Wang R
Peptides; 2006 Sep; 27(9):2207-13. PubMed ID: 16762456
[TBL] [Abstract][Full Text] [Related]
12. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
Chen SH; Cheung RT
J Biomed Sci; 2005; 12(2):267-78. PubMed ID: 15942706
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
20. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
Penner SB; Smyth DD; Glavin GB
J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
